Company Overview
Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company
developing and commercializing tamper-resistant products to combat
medication abuse and misuse. The Centers for Disease Control and
Prevention estimates that one person dies every 19 minutes from
prescription drug abuse in the United States. For nearly a decade, Acura
has been on the forefront of developing solutions to combat this
epidemic, with products utilizing the Company’s proprietary abuse
deterrent AVERSION® and IMPEDE® Technologies.
The first two commercial products utilizing Acura’s tamper-resistant technologies are OXAYDOTM and NEXAFED®. In addition, Acura has seven other abuse deterrent products in development: Hydrocodone bitartrate/acetaminophen tablets, Oxycodone HCl/acetaminophen tablets, Hydromorphone tablets, Morphine tablets, Oxymorphone tablets, Tramadol tablets and Methadone tablets.
The first two commercial products utilizing Acura’s tamper-resistant technologies are OXAYDOTM and NEXAFED®. In addition, Acura has seven other abuse deterrent products in development: Hydrocodone bitartrate/acetaminophen tablets, Oxycodone HCl/acetaminophen tablets, Hydromorphone tablets, Morphine tablets, Oxymorphone tablets, Tramadol tablets and Methadone tablets.
No comments:
Post a Comment